Article
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Breast cancer research and treatment - 1 Apr 2012
Stebbing Justin, Filipovic Aleksandra, Ellis Ian O, Green Andrew R, D'Silva Tanya Rapoz, Lenz Heinz-Josef, Coombes R Charles, Wang Tingting, Lee Soo-Chin, Giamas Georgios
Abstract excerpt
Interactions between kinases and the estrogen receptor α (ERα) are thought to be a critical signaling pathway in the majority of human breast cancers. We have recently identified a previously uncharacterized molecule, lemur tyrosine kinase-3 (LMTK3) as a prognostic and predictive oncogenic ERα regulator with a central role in endocrine resistance. Unusually this protein has undergone Darwinian positive selection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
